Press release
Key Trends Reshaping the Hypoparathyroidism Market: Transcon Platform Enables Long-Acting Prodrugs For Sustained Hormone Release Industry Transformation
Hypoparathyroidism
Hypoparathyroidism Market Size Growth Forecast: What to Expect by 2025?
In recent times, the hypoparathyroidism market has experienced robust growth. The market size, which stands at $0.95 billion in 2024, is projected to expand to $1.03 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. This historical growth is due to factors such as the growing number of thyroid surgeries, increased awareness about hypoparathyroidism, a surge in post-operative complications, a rise in the demand for calcium and vitamin D supplements, and an enhanced focus on the management of endocrine disorders.
How Will the Hypoparathyroidism Market Size Evolve and Grow by 2029?
The market for hypoparathyroidism is predicted to experience substantial growth in the upcoming years, with expectations of reaching $1.42 billion in 2029, indicating a compound annual growth rate (CAGR) of 8.3%. This projected growth during the forecast period can be traced back to the increasing incorporation of recombinant parathyroid hormone therapies, escalating investment in hypoparathyroidism research, expansion of the healthcare sector, a growing elderly demographic susceptible to endocrine disorders, and rising awareness leading to early diagnosis. The forecast period is also expected to witness advancements in parathyroid hormone therapies, enhanced diagnostic procedures for hypoparathyroidism, emergence of sustained-release calcium supplements, innovations in minimally invasive thyroid surgery, and further advancements in patient monitoring technologies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/hypoparathyroidism-global-market-report
What Drivers Are Propelling the Growth of Hypoparathyroidism Market Forward?
Rising cases of thyroid cancer are anticipated to fuel the expansion of the hypoparathyroidism market in the future. Thyroid cancer involves the abnormal growth of cells in the thyroid gland, often appearing as a lump in the neck. Improved diagnostic imaging technologies have led to increasing instances of thyroid cancer, as these technologies facilitate early and more regular detection of small, symptomless thyroid nodules. Hypoparathyroidism is indirectly prompted by thyroid cancer due to the increased need for thyroid surgeries, which can unintentionally harm the parathyroid glands. This results in calcium imbalance and persistent hormone deficiency, thereby increasing the need for enduring disease management solutions. For example, the American Cancer Society, a not-for-profit organization based in the US, reported in May 2024 that the number of new thyroid cancer cases surged to 44,020 in 2025 from 43,720 in 2023. Consequently, the escalating instances of thyroid cancer are spurring the growth of the hypoparathyroidism market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24565&type=smp
Which Emerging Trends Are Transforming the Hypoparathyroidism Market in 2025?
Leading companies in the hypoparathyroidism market are striving to create more technologically sophisticated products, such as those based on transition technology, to boost treatment effectiveness and better patient outcomes. These transition technology-based products are therapeutics created with TransCon (Transient Conjugation) technology, an exclusive platform aimed at enhancing drug delivery capabilities. For example, in January 2024, Ascendis Pharma A/S, a biopharmaceutical enterprise based in Denmark, introduced YORVIPATH (palopegteriparatide), its second product using TransCon technology, in Germany and Austria to treat adults suffering from chronic hypoparathyroidism. YORVIPATH is a once-a-day prodrug of parathyroid hormone (PTH 1-34) which aims to sustain physiological PTH levels throughout a 24-hour period, targeting the foundational hormone deficiency found in chronic hypoparathyroidism.
What Are the Key Segments in the Hypoparathyroidism Market?
The hypoparathyroidism market covered in this report is segmented -
1) By Treatment: Hormone Replacement Therapy, Adjunctive Therapies
2) By Type: Hormone Replacement Therapy, Calcium And Vitamin D Supplements, Emerging Therapies
3) By Route Of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End User: Hospitals, Specialty Clinics, Homecare Settings
Subsegments:
1) By Hormone Replacement Therapy: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues, Calcimimetics, Calcium And Vitamin D Supplements
2) By Adjunctive Therapies: Magnesium Supplements, Phosphate Binders, Other Supportive Therapies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24565&type=smp
Who Are the Key Players Shaping the Hypoparathyroidism Market's Competitive Landscape?
Major companies operating in the hypoparathyroidism market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline plc , Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited , Lupin Limited, Torrent Pharmaceuticals Ltd., Eagle Pharmaceuticals Inc., BridgeBio Pharma Inc., Ascendis Pharma A/S, Extend Biosciences Inc., Entera Bio Ltd.
What Geographic Markets Are Powering Growth in the Hypoparathyroidism Market?
North America was the largest region in the hypoparathyroidism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hypoparathyroidism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24565
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Trends Reshaping the Hypoparathyroidism Market: Transcon Platform Enables Long-Acting Prodrugs For Sustained Hormone Release Industry Transformation here
News-ID: 4092772 • Views: …
More Releases from The Business Research Company
Emerging Trends to Reshape the Xenotransplantation Market: Xvivo's Innovative Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Xenotransplantation Market Size By 2025?
The market size of xenotransplantation has seen robust expansion in the past few years. The market value is projected to increase from $14.68 billion in 2024 to $15.82 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.8%.…
Wood Based Panel Market Landscape to 2034: Key Forces Shaping the Next Decade of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Wood Based Panel Market Through 2025?
In recent times, the market size of wood-based panels has seen considerable growth. The market which was valued at $176.85 billion in 2024 is projected to rise to $190.52 billion in 2025, showing a compound annual…
Soaring Demand Set to Propel Wireless Speakers Market to $111.25 Billion by 2029
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Wireless Speakers Market Size Growth Forecast: What to Expect by 2025?
In recent times, the wireless speakers market has experienced substantial expansion. The market size is expected to increase from $37.14 billion in 2024 to $45.71 billion in 2025, growing at a compound annual growth rate (CAGR) of 23.1%.…
Wind Turbine Casting Market Landscape 2025: Forecast Data and Growth Strategy In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Wind Turbine Casting Industry Market Size Be by 2025?
The market size for wind turbine castings has seen solid growth in the past few years. Its value is projected to increase from $2.31 billion in 2024 to $2.46 billion in 2025, with a compound annual growth…
More Releases for Hypoparathyroidism
Hypoparathyroidism Market Size, Development, Key Opportunity, Application & Fore …
The global hypoparathyroidism market was valued at approximately $1.3 billion in 2023 and is projected to reach around $2.5 billion by 2031. This represents a compound annual growth rate (CAGR) of about 8.8%.
Request a Free Sample Copy@ https://www.datalibraryresearch.com/sample-request/hypoparathyroidism-market-5438
With market research reports garnering immense significance in the speedily transforming market place, the team at Data Library Research endows with Hypoparathyroidism Market report in a way which is predicted. It comprehensively…
Hypoparathyroidism Drug Market: An Overview
Hypoparathyroidism is a rare endocrine disorder characterized by insufficient production of parathyroid hormone (PTH), leading to low calcium levels in the blood. This deficiency causes various complications, including muscle cramps, fatigue, and neurological issues. Managing hypoparathyroidism primarily involves calcium and vitamin D supplements, but newer treatments targeting PTH replacement therapy have emerged, providing more effective and sustainable solutions.
The development of hypoparathyroidism drugs represents a promising area of growth in the…
Hypoparathyroidism Drug Market Size, Share, Trends, Demand, Growth and Competiti …
"Hypoparathyroidism Drug Market business report provides a profound overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. The data and information collected to generate this top-notch market report has been derived from the trusted sources such as company websites, white papers, journals, and mergers etc. Hypoparathyroidism Drug Market report includes basic, secondary and advanced information related to the global…
Hypoparathyroidism Drug Market Size, Share, Trends, Growth and Competitive Analy …
Hypoparathyroidism Drug Market business report provides a profound overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. The data and information collected to generate this top-notch market report has been derived from the trusted sources such as company websites, white papers, journals, and mergers etc. Hypoparathyroidism Drug Market report includes basic, secondary and advanced information related to the global…
Hypoparathyroidism Treatment Market Size 2024 to 2031.
Market Overview and Report Coverage
Hypoparathyroidism is a rare condition where the parathyroid glands in the neck produce too little parathyroid hormone, resulting in low calcium levels in the blood. The primary treatment for hypoparathyroidism involves calcium and vitamin D supplementation, as well as hormonal therapy.
The future outlook for the Hypoparathyroidism Treatment Market is promising, with a projected growth rate of 20.00% during the forecasted period. This growth can…
Hypoparathyroidism Treatment Market Size, Share, Trends, Analysis and Forecast 2 …
The Global Hypoparathyroidism Treatment Market is poised to register a CAGR of over 8% during the forecast period 2020 to 2027.
Hypoparathyroidism occurs when the parathyroid glands does not produce enough hormone. Hyperparathyroidism can be caused by a number of factors, including injury or removal of the parathyroid glands, DiGeorge syndrome, an autoimmune disease, cancer radiation treatment, and low magnesium levels. The main function of parathyroid hormone is to regulate blood…
